CAPRICOR THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $6.8M | $3.9M |
| FY2020 | — | $28.2M | $32.7M |
| FY2021 | — | $31.4M | $34.9M |
| FY2022 | — | $11.8M | $9.6M |
| FY2023 | — | $22.6M | $14.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $6.8M | $3.9M |
| FY2020 | — | $28.2M | $32.7M |
| FY2021 | — | $31.4M | $34.9M |
| FY2022 | — | $11.8M | $9.6M |
| FY2023 | — | $22.6M | $14.7M |